FI
SGYP

Fosun International’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Fosun International’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-506,582
Closed -$2.79M – 28
2016
Q3 		$2.79M Buy
+506,582
New +$2.37M 0.31% 25

Other funds holding SGYP

PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Fosun International's SGYP Position: Q4 2016 in Review

Fosun International sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2016, closing a stake of 506,582 shares — an estimated $2.79M sold.

Fosun International first reported a position in SGYP in Q3 2016 and held it in 1 quarter. The position peaked at $2.79M in Q3 2016. 156 funds tracked by Wall St. Rank hold SGYP as of Q4 2016.

  • Fosun International reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2016 after selling out during the quarter.
  • Fosun International sold 506,582 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2016, an estimated $2.79M.
  • Fosun International first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q3 2016 and held it in 1 quarter.
  • Fosun International's Synergy Pharmaceuticals, Inc Common Stock position peaked at $2.79M in Q3 2016.
  • 156 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2016.

Based on Fosun International's 13F filing for Q4 2016, filed 13 Feb 2017.